National Healthcare Stock Performance
| NHC Stock | USD 125.85 2.51 2.04% |
The company secures a Beta (Market Risk) of 1.79, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, National HealthCare will likely underperform. At this point, National HealthCare has a negative expected return of -0.0501%. Please make sure to verify National HealthCare's daily balance of power, and the relationship between the skewness and day typical price , to decide if National HealthCare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days National HealthCare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, National HealthCare is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return 0.81 | Five Day Return (1.44) | Year To Date Return 36.07 | Ten Year Return 107.13 | All Time Return 7.4 K |
Forward Dividend Yield 0.0198 | Payout Ratio 0.3007 | Forward Dividend Rate 2.44 | Dividend Date 2025-01-31 | Ex Dividend Date 2024-12-30 |
1 | Disposition of 8000 shares by Timothy Shelly of National HealthCare at 94.1 subject to Rule 16b-3 | 08/30/2024 |
2 | Acquisition by W Adams of 7500 shares of National HealthCare at 77.92 subject to Rule 16b-3 | 10/04/2024 |
3 | ASX 200 coal stock has multiyear levers to offset volatile commodity prices | 10/24/2024 |
| National HealthCare dividend paid on 1st of November 2024 | 11/01/2024 |
4 | SOL and Goodman Group 2 ASX shares to dig into | 11/04/2024 |
5 | Morgan Stanleys Strategic Acquisition of Shares in National Healthcare Corp | 11/08/2024 |
6 | The SOL share price and GMG share price in focus | 11/13/2024 |
7 | Investors in New Hope have seen strong returns of 240 percent over the past three years | 11/18/2024 |
| Begin Period Cash Flow | 73.8 M |
National |
National HealthCare Relative Risk vs. Return Landscape
If you would invest 13,179 in National HealthCare on August 24, 2024 and sell it today you would lose (594.00) from holding National HealthCare or give up 4.51% of portfolio value over 90 days. National HealthCare is generating negative expected returns assuming volatility of 2.1166% on return distribution over 90 days investment horizon. In other words, 18% of stocks are less volatile than National, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
National HealthCare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for National HealthCare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as National HealthCare, and traders can use it to determine the average amount a National HealthCare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0237
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NHC |
Estimated Market Risk
| 2.12 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average National HealthCare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of National HealthCare by adding National HealthCare to a well-diversified portfolio.
National HealthCare Fundamentals Growth
National Stock prices reflect investors' perceptions of the future prospects and financial health of National HealthCare, and National HealthCare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on National Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0288 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.93 B | ||||
| Shares Outstanding | 15.44 M | ||||
| Price To Earning | 22.85 X | ||||
| Price To Book | 1.98 X | ||||
| Price To Sales | 1.59 X | ||||
| Revenue | 1.14 B | ||||
| Gross Profit | 388.11 M | ||||
| EBITDA | 87.99 M | ||||
| Net Income | 66.8 M | ||||
| Cash And Equivalents | 58.67 M | ||||
| Cash Per Share | 14.19 X | ||||
| Total Debt | 93.39 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 1.76 X | ||||
| Book Value Per Share | 63.69 X | ||||
| Cash Flow From Operations | 111.22 M | ||||
| Earnings Per Share | 7.99 X | ||||
| Market Capitalization | 1.9 B | ||||
| Total Asset | 1.31 B | ||||
| Retained Earnings | 687.6 M | ||||
| Working Capital | 191.76 M | ||||
| Current Asset | 164.61 M | ||||
| Current Liabilities | 114.08 M | ||||
About National HealthCare Performance
By analyzing National HealthCare's fundamental ratios, stakeholders can gain valuable insights into National HealthCare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if National HealthCare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if National HealthCare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 2.59 | 2.46 | |
| Return On Tangible Assets | 0.06 | 0.06 | |
| Return On Capital Employed | 1.04 | 1.09 | |
| Return On Assets | 0.05 | 0.06 | |
| Return On Equity | 0.07 | 0.07 |
Things to note about National HealthCare performance evaluation
Checking the ongoing alerts about National HealthCare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for National HealthCare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| National HealthCare generated a negative expected return over the last 90 days | |
| About 61.0% of the company shares are owned by institutional investors | |
| On 1st of November 2024 National HealthCare paid $ 0.61 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Disposition of 8000 shares by Timothy Shelly of National HealthCare at 94.1 subject to Rule 16b-3 |
- Analyzing National HealthCare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether National HealthCare's stock is overvalued or undervalued compared to its peers.
- Examining National HealthCare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating National HealthCare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of National HealthCare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of National HealthCare's stock. These opinions can provide insight into National HealthCare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for National Stock analysis
When running National HealthCare's price analysis, check to measure National HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National HealthCare is operating at the current time. Most of National HealthCare's value examination focuses on studying past and present price action to predict the probability of National HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National HealthCare's price. Additionally, you may evaluate how the addition of National HealthCare to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |